The inhibition of either NRG1 or PAK1 activity (BD+anti-NRG1+LT and BD+anti-PAK1+LT groups) increased ALP, bilirubin, vWF, and HA levels, in comparison with the BD+LT group, and in both liver types (Supplementary Figure S2). Here, VWF is linked to Behcet disease.